Please wait

 

 

 

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of January, 2026

 

COMMISSION FILE NUMBER 001-34041

 

Evotec SE
(Translation of registrant’s name into English)

 

Essener Bogen 7 

22419 Hamburg 

Germany 

Tel: +49 40 560810
(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F: Form 20-F x Form 40-F ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

 

 

 

 

 

 

On January 8, 2026, Evotec SE (the “Company”) issued a press release announcing the receipt of a new grant from the Gates Foundation, attached hereto as Exhibit 99.1, and submitted a Notification of Major Holdings to Bundesanstalt für Finanzdienstleistungsaufsicht, pursuant to German Law, attached hereto as Exhibit 99.2.

 

EXHIBIT INDEX

 

 

Exhibit  Description of Exhibit
99.1  Just – Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access
99.2  Notification of Major Holdings (JPM), dated January 8, 2026

 

 

 

 

SIGNATURE

 

Pursuant to the requirements, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Evotec SE
     
  By: /s/ Christian Wojczewski
    Name: Christian Wojczewski
    Title: Chief Executive Officer

 

Date: January 8, 2026